-
1
-
-
0001163006
-
Cancer of the lung
-
DeVita VT, Hellman S, Rosenberg SA, eds. Philadelphia, PA: Lippincott-Raven
-
Ginsberg RJ, Vokes EE, Raben A. Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia, PA: Lippincott-Raven, 1999; 849-950
-
(1999)
Cancer: Principles and Practice of Oncology
, pp. 849-950
-
-
Ginsberg, R.J.1
Vokes, E.E.2
Raben, A.3
-
2
-
-
0027941826
-
Variation in the management and outcome of non-small cell lung cancer in Ontario
-
Mackillop WJ, Zhou Y, Dixon P, et al. Variation in the management and outcome of non-small cell lung cancer in Ontario. Radiother Oncol 1994; 32:106-115
-
(1994)
Radiother Oncol
, vol.32
, pp. 106-115
-
-
Mackillop, W.J.1
Zhou, Y.2
Dixon, P.3
-
3
-
-
0015306697
-
Clinical biostatistics XIV: The purposes of prognostic stratification
-
Feinstein AR. Clinical biostatistics XIV: the purposes of prognostic stratification. Clin Pharmacol Ther 1972; 13:285-297
-
(1972)
Clin Pharmacol Ther
, vol.13
, pp. 285-297
-
-
Feinstein, A.R.1
-
4
-
-
0035281919
-
Phase I study of a decision aid for patients with locally advanced non-small cell lung cancer
-
Brundage MD, Feldman-Stewart D, Cosby R, et al. Phase I study of a decision aid for patients with locally advanced non-small cell lung cancer. J Clin Oncol 2001; 19:1326-1335
-
(2001)
J Clin Oncol
, vol.19
, pp. 1326-1335
-
-
Brundage, M.D.1
Feldman-Stewart, D.2
Cosby, R.3
-
5
-
-
0002124406
-
The importance of prognosis in cancer medicine
-
Gospodarowicz MK, Henson DE, Hutter RBP, et al, eds. New York, NY: Wiley & Sons
-
Mackillop WJ. The importance of prognosis in cancer medicine. In: Gospodarowicz MK, Henson DE, Hutter RBP, et al, eds. Prognostic factors in cancer. New York, NY: Wiley & Sons, 2001
-
(2001)
Prognostic Factors in Cancer
-
-
Mackillop, W.J.1
-
6
-
-
0028048944
-
Prognostic factors in lung cancer: Tables and comments
-
Buccheri G, Ferrigno D. Prognostic factors in lung cancer: tables and comments. Eur Respir J 1994; 7:1350-1364
-
(1994)
Eur Respir J
, vol.7
, pp. 1350-1364
-
-
Buccheri, G.1
Ferrigno, D.2
-
7
-
-
0027972129
-
Prognostic factors in non-small cell lung cancer
-
Feld R, Borges M, Giner V, et al. Prognostic factors in non-small cell lung cancer. Lung Cancer 1994; 11(suppl):S19-S23
-
(1994)
Lung Cancer
, vol.11
, pp. S19-S23
-
-
Feld, R.1
Borges, M.2
Giner, V.3
-
8
-
-
0029885852
-
New prognostic factors in resectable non-small cell lung cancer
-
Smit EF, Groen HJ, Splinter TA, et al. New prognostic factors in resectable non-small cell lung cancer. Thorax 1996; 51:638-646
-
(1996)
Thorax
, vol.51
, pp. 638-646
-
-
Smit, E.F.1
Groen, H.J.2
Splinter, T.A.3
-
9
-
-
0029046361
-
New prognostic factors in lung cancer: Biologic prophets of cancer cell aggression
-
Mountain CF. New prognostic factors in lung cancer: biologic prophets of cancer cell aggression. Chest 1995; 108:246-254
-
(1995)
Chest
, vol.108
, pp. 246-254
-
-
Mountain, C.F.1
-
10
-
-
0030912190
-
Revisions in the international system for staging lung cancer
-
Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717
-
(1997)
Chest
, vol.111
, pp. 1710-1717
-
-
Mountain, C.F.1
-
11
-
-
84971581087
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
-
Stewart LA, Pignon JP. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311:899-909
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
Stewart, L.A.1
Pignon, J.P.2
-
12
-
-
0025826624
-
Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience
-
Albain KS, Crowley JJ, LeBlanc M, et al. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991; 9:1618-1626
-
(1991)
J Clin Oncol
, vol.9
, pp. 1618-1626
-
-
Albain, K.S.1
Crowley, J.J.2
LeBlanc, M.3
-
13
-
-
0029030143
-
Prognostic factors for survival in advanced non-small-cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients: The European Lung Cancer Working Party
-
Paesmans M, Sculier JP, Libert P, et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univar-iate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients: the European Lung Cancer Working Party. J Clin Oncol 1995; 13:1221-1230
-
(1995)
J Clin Oncol
, vol.13
, pp. 1221-1230
-
-
Paesmans, M.1
Sculier, J.P.2
Libert, P.3
-
14
-
-
0029588645
-
Survival predictors in advanced non-small cell lung cancer
-
Hespanhol V, Queiroga H, Magalhaes A, et al. Survival predictors in advanced non-small cell lung cancer. Lung Cancer 1995; 13:253-267
-
(1995)
Lung Cancer
, vol.13
, pp. 253-267
-
-
Hespanhol, V.1
Queiroga, H.2
Magalhaes, A.3
-
15
-
-
0030220305
-
Prognostic factors for patients with advanced non-small cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation
-
Takigawa N, Segawa Y, Okahara M, et al. Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer 1996; 15:67-77
-
(1996)
Lung Cancer
, vol.15
, pp. 67-77
-
-
Takigawa, N.1
Segawa, Y.2
Okahara, M.3
-
16
-
-
0025761204
-
Quality of life assessment: An independent prognostic variable for survival in lung cancer
-
Ganz PA, Lee JJ, Siau J. Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 1991; 67:3131-3135
-
(1991)
Cancer
, vol.67
, pp. 3131-3135
-
-
Ganz, P.A.1
Lee, J.J.2
Siau, J.3
-
17
-
-
0030757244
-
Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy
-
Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997; 33:1025-1030
-
(1997)
Eur J Cancer
, vol.33
, pp. 1025-1030
-
-
Coates, A.1
Porzsolt, F.2
Osoba, D.3
-
18
-
-
0032916512
-
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
-
Herndon JE, Fleishman S, Kornblith AB, et al. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999; 85:333-340
-
(1999)
Cancer
, vol.85
, pp. 333-340
-
-
Herndon, J.E.1
Fleishman, S.2
Kornblith, A.B.3
-
19
-
-
0035144762
-
Quality of life in lung cancer patients: As an important prognostic factor
-
Montazeri A, Milroy R, Hole D, et al. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 2001; 31:233-240
-
(2001)
Lung Cancer
, vol.31
, pp. 233-240
-
-
Montazeri, A.1
Milroy, R.2
Hole, D.3
-
20
-
-
0034176511
-
The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy
-
Langendijk H, Aaronson NK, de Jong JM, et al. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000; 55:19-25
-
(2000)
Radiother Oncol
, vol.55
, pp. 19-25
-
-
Langendijk, H.1
Aaronson, N.K.2
De Jong, J.M.3
-
21
-
-
85007195355
-
Lung
-
Perez CA, ed. Philadelphia, PA: Lippincott
-
Emami B, Perez CA. Lung. In: Perez CA, ed. Radiation oncology. Philadelphia, PA: Lippincott, 1993
-
(1993)
Radiation Oncology
-
-
Emami, B.1
Perez, C.A.2
-
22
-
-
0022979539
-
Factors affecting survival in superior sulcus tumors
-
Anderson TM, Moy PM, Holmes EC. Factors affecting survival in superior sulcus tumors. J Clin Oncol 1986; 4:1598-1603
-
(1986)
J Clin Oncol
, vol.4
, pp. 1598-1603
-
-
Anderson, T.M.1
Moy, P.M.2
Holmes, E.C.3
-
24
-
-
0030761847
-
Pancoast (superior sulcus) tumors
-
Detterbeck FC. Pancoast (superior sulcus) tumors. Ann Thorac Surg 1997; 63:1810-1818
-
(1997)
Ann Thorac Surg
, vol.63
, pp. 1810-1818
-
-
Detterbeck, F.C.1
-
25
-
-
0021268776
-
Pancoast's tumor
-
Shaw RR. Pancoast's tumor. Ann Thorac Surg 1984; 37:343-345
-
(1984)
Ann Thorac Surg
, vol.37
, pp. 343-345
-
-
Shaw, R.R.1
-
27
-
-
0025169821
-
A clinical-severity staging system for patients with lung cancer
-
Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine (Baltimore) 1990; 69:1-33
-
(1990)
Medicine (Baltimore)
, vol.69
, pp. 1-33
-
-
Feinstein, A.R.1
Wells, C.K.2
-
29
-
-
0035192929
-
Predictive factors in radiotherapy for non-small cell lung cancer: Present status
-
Choi N, Baumann M, Flentjie M, et al. Predictive factors in radiotherapy for non-small cell lung cancer: present status. Lung Cancer 2001; 31:43-56
-
(2001)
Lung Cancer
, vol.31
, pp. 43-56
-
-
Choi, N.1
Baumann, M.2
Flentjie, M.3
-
30
-
-
0030831308
-
Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: Are they useful?
-
Mori M, Kohli A, Baker SP, et al. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful? Mod Pathol 1997; 10:572-577
-
(1997)
Mod Pathol
, vol.10
, pp. 572-577
-
-
Mori, M.1
Kohli, A.2
Baker, S.P.3
-
31
-
-
0030996171
-
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study
-
Fontanini G, Lucchi M, Vignati S, et al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst 1997; 89:881-886
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 881-886
-
-
Fontanini, G.1
Lucchi, M.2
Vignati, S.3
-
32
-
-
0024222236
-
The spectrum and significance of bronchioloalveolar carcinomas
-
Clayton F. The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 1988; 23:361-394
-
(1988)
Pathol Annu
, vol.23
, pp. 361-394
-
-
Clayton, F.1
-
33
-
-
0030904756
-
Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behavior
-
Perkins P, Kemp BL, Putnam JBJ, et al. Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behavior. Am J Clin Oncol 1997; 20:285-288
-
(1997)
Am J Clin Oncol
, vol.20
, pp. 285-288
-
-
Perkins, P.1
Kemp, B.L.2
Putnam, J.B.J.3
-
34
-
-
0029911353
-
Carcinoid tumors of the lung: Immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically
-
Kayser K, Kayser C, Rahn W, et al. Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically. J Surg Oncol 1996; 63:99-106
-
(1996)
J Surg Oncol
, vol.63
, pp. 99-106
-
-
Kayser, K.1
Kayser, C.2
Rahn, W.3
-
35
-
-
0032959632
-
A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers
-
D'Amico TA, Massey M, Herndon JE, et al. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. Thorac Cardiovasc Surg 1999; 117:736-743
-
(1999)
Thorac Cardiovasc Surg
, vol.117
, pp. 736-743
-
-
D'Amico, T.A.1
Massey, M.2
Herndon, J.E.3
-
36
-
-
0029064674
-
Biologic and molecular prognostic factors: Impact on treatment of patients with non-small cell lung cancer
-
Johnson BE. Biologic and molecular prognostic factors: impact on treatment of patients with non-small cell lung cancer. Chest 1995; 107:287S-290S
-
(1995)
Chest
, vol.107
, pp. 287S-290S
-
-
Johnson, B.E.1
-
37
-
-
0029765583
-
Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer
-
Goto I, Yoneda S, Yamamoto M, et al. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer. Cancer Res 1996; 56:3725-3730
-
(1996)
Cancer Res
, vol.56
, pp. 3725-3730
-
-
Goto, I.1
Yoneda, S.2
Yamamoto, M.3
-
38
-
-
0031764876
-
Further comments on "A practical prognostic index for inoperable non-small-cell lung cancer": A clinical biologist's point of view
-
Watine J. Further comments on "A practical prognostic index for inoperable non-small-cell lung cancer": a clinical biologist's point of view. J Cancer Res Clin Oncol 1998; 124:581-583
-
(1998)
J Cancer Res Clin Oncol
, vol.124
, pp. 581-583
-
-
Watine, J.1
-
40
-
-
0010588929
-
Deregulation of the cell cycle in lung cancer
-
Brambilla C, Brambilla E, eds. New York, NY: Marcel Dekker
-
Michalides RJ. Deregulation of the cell cycle in lung cancer. In: Brambilla C, Brambilla E, eds. Lung tumors: fundamental biology and clinical management. New York, NY: Marcel Dekker, 1999
-
(1999)
Lung Tumors: Fundamental Biology and Clinical Management
-
-
Michalides, R.J.1
-
41
-
-
0034729357
-
Prognostic significance of p53 mutations in non-small cell lung cancer: A meta-analysis of 829 cases from eight published studies
-
Huncharek M, Kupelnick B, Geschwind JF, et al. Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies. Cancer Lett 2000; 153:219-226
-
(2000)
Cancer Lett
, vol.153
, pp. 219-226
-
-
Huncharek, M.1
Kupelnick, B.2
Geschwind, J.F.3
-
42
-
-
0033765491
-
Prognostic significance of p53 alterations in patients with non-small cell lung cancer: A meta-analysis
-
Mitsudomi T, Hamajima N, Ogawa M, et al. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 2000; 6:4055-4063
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4055-4063
-
-
Mitsudomi, T.1
Hamajima, N.2
Ogawa, M.3
-
43
-
-
0035816267
-
Aneuploidy and prognosis of non-small-cell lung cancer: A meta-analysis of published data
-
Choma D, Daures JP, Quantin X, et al. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data. Br J Cancer 2001; 85:14-22
-
(2001)
Br J Cancer
, vol.85
, pp. 14-22
-
-
Choma, D.1
Daures, J.P.2
Quantin, X.3
-
44
-
-
0033994195
-
Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA
-
van Rens MT, de la Riviere AB, Elbers HR, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000; 117:374-379
-
(2000)
Chest
, vol.117
, pp. 374-379
-
-
Van Rens, M.T.1
De la Riviere, A.B.2
Elbers, H.R.3
-
46
-
-
0026759013
-
New aspects in the staging of lung cancer: Prospective validation of the International Union Against Cancer TNM classification
-
Bulzebruck H, Bopp R, Drings P, et al. New aspects in the staging of lung cancer: prospective validation of the International Union Against Cancer TNM classification. Cancer 1992; 70:1102-1110
-
(1992)
Cancer
, vol.70
, pp. 1102-1110
-
-
Bulzebruck, H.1
Bopp, R.2
Drings, P.3
-
47
-
-
0034035234
-
Prognostic value of stage grouping and TNM descriptors in lung cancer
-
Buccheri G, Ferrigno D. Prognostic value of stage grouping and TNM descriptors in lung cancer. Chest 2000; 117:1247-1255
-
(2000)
Chest
, vol.117
, pp. 1247-1255
-
-
Buccheri, G.1
Ferrigno, D.2
-
48
-
-
0034099593
-
Results of surgical treatment of non-small cell lung cancer: Validation of the new postoperative pathologic TNM classification
-
Jassem J, Skokowski J, Dziadziuszko R, et al. Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. Thorac Cardiovasc Surg 2000; 119:1141-1146
-
(2000)
Thorac Cardiovasc Surg
, vol.119
, pp. 1141-1146
-
-
Jassem, J.1
Skokowski, J.2
Dziadziuszko, R.3
-
49
-
-
0033396816
-
Lung cancer treatment decisions: Patients' desires for participation and information
-
Davidson JR, Brundage MD, Feldman-Stewart D. Lung cancer treatment decisions: patients' desires for participation and information. Psychooncology 1999; 8:511-520
-
(1999)
Psychooncology
, vol.8
, pp. 511-520
-
-
Davidson, J.R.1
Brundage, M.D.2
Feldman-Stewart, D.3
-
50
-
-
0031748935
-
Using a treatment-tradeoff methods to elicit preferences for the treatment of locally advanced non-small cell lung cancer
-
Brundage MD, Davidson JR, Mackillop W, et al. Using a treatment-tradeoff methods to elicit preferences for the treatment of locally advanced non-small cell lung cancer. Med Decis Making 1998; 18:256-267
-
(1998)
Med Decis Making
, vol.18
, pp. 256-267
-
-
Brundage, M.D.1
Davidson, J.R.2
Mackillop, W.3
-
51
-
-
0026752542
-
Prognostic value of the tissue polypeptide antigen in lung cancer
-
Buccheri G, Ferrigno D. Prognostic value of the tissue polypeptide antigen in lung cancer. Chest 1992; 101:1287-1292
-
(1992)
Chest
, vol.101
, pp. 1287-1292
-
-
Buccheri, G.1
Ferrigno, D.2
-
52
-
-
0029985164
-
Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients
-
Palomares MR, Sayre JW, Shekar KC, et al. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer 1996; 78:2119-2126
-
(1996)
Cancer
, vol.78
, pp. 2119-2126
-
-
Palomares, M.R.1
Sayre, J.W.2
Shekar, K.C.3
-
53
-
-
0026477527
-
The use of discriminant analysis to guide palliative treatment for lung cancer patients
-
Thorogood J, Bulman AS, Collins T, et al. The use of discriminant analysis to guide palliative treatment for lung cancer patients. Clin Oncol (R Coll Radiol) 1992; 4:22-26
-
(1992)
Clin Oncol (R Coll Radiol)
, vol.4
, pp. 22-26
-
-
Thorogood, J.1
Bulman, A.S.2
Collins, T.3
-
54
-
-
0029819443
-
Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma
-
Takai E, Yano T, Iguchi H, et al. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma. Cancer 1996; 78:1384-1387
-
(1996)
Cancer
, vol.78
, pp. 1384-1387
-
-
Takai, E.1
Yano, T.2
Iguchi, H.3
-
55
-
-
0030176378
-
Performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution
-
Buccheri G, Ferrigno D, Tamburini M Karnofsky, and ECOG. performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996; 32A:1135-1141
-
(1996)
Eur J Cancer
, vol.32 A
, pp. 1135-1141
-
-
Buccheri, G.1
Ferrigno, D.2
Tamburini, M.K.3
-
56
-
-
0026090161
-
Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment
-
Bonomi P, Gale M, Rowland K, et al. Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment. Int J Radiat Oncol Biol Phys 1991; 20:247-252
-
(1991)
Int J Radiat Oncol Biol Phys
, vol.20
, pp. 247-252
-
-
Bonomi, P.1
Gale, M.2
Rowland, K.3
-
57
-
-
0031041775
-
Prognostic value of pleural effusion in patients with non-small cell lung cancer
-
Sugiura S, Ando Y, Minami H, et al. Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 1997; 3:47-50
-
(1997)
Clin Cancer Res
, vol.3
, pp. 47-50
-
-
Sugiura, S.1
Ando, Y.2
Minami, H.3
-
58
-
-
0027715951
-
Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: Comparison with CALGB 8433
-
Komaki R, Pajak TF, Byhardt RW, et al. Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433. Lung Cancer 1993; 10:189-197
-
(1993)
Lung Cancer
, vol.10
, pp. 189-197
-
-
Komaki, R.1
Pajak, T.F.2
Byhardt, R.W.3
-
59
-
-
0032991503
-
Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer
-
Ando M, Ando Y, Sugiura S, et al. Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer. Jpn J Cancer Res 1999; 90:249-253
-
(1999)
Jpn J Cancer Res
, vol.90
, pp. 249-253
-
-
Ando, M.1
Ando, Y.2
Sugiura, S.3
-
60
-
-
0030739929
-
Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer
-
Wigren T. Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer. Radiother Oncol 1997; 44:9-15
-
(1997)
Radiother Oncol
, vol.44
, pp. 9-15
-
-
Wigren, T.1
-
61
-
-
0027201887
-
Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer
-
Kreisman H, Lisbona A, Olson L, et al. Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer. Cancer 1993; 72:1588-1596
-
(1993)
Cancer
, vol.72
, pp. 1588-1596
-
-
Kreisman, H.1
Lisbona, A.2
Olson, L.3
-
62
-
-
0344628764
-
Trimodality therapy in stage III non-small cell lung cancer: Prediction of recurrence by assessment of p185neu
-
Thomas M, Rube C, Semik M, et al. Trimodality therapy in stage III non-small cell lung cancer: prediction of recurrence by assessment of p185neu. Eur Respir J 1999; 13:424-429
-
(1999)
Eur Respir J
, vol.13
, pp. 424-429
-
-
Thomas, M.1
Rube, C.2
Semik, M.3
-
63
-
-
0031409715
-
Pleural effusion as a significant prognostic factor in non-small cell lung cancer
-
Naito T, Satoh H, Ishikawa H, et al. Pleural effusion as a significant prognostic factor in non-small cell lung cancer. Anticancer Res 1997; 17:4743-4746
-
(1997)
Anticancer Res
, vol.17
, pp. 4743-4746
-
-
Naito, T.1
Satoh, H.2
Ishikawa, H.3
-
64
-
-
0027313590
-
Prognostic factors in lung cancer based on multivariate analysis
-
Hilsenbeck SG, Raub WAJ, Sridhar KS. Prognostic factors in lung cancer based on multivariate analysis. Am J Clin Oncol 1993; 16:301-309
-
(1993)
Am J Clin Oncol
, vol.16
, pp. 301-309
-
-
Hilsenbeck, S.G.1
Raub, W.A.J.2
Sridhar, K.S.3
-
65
-
-
0031030245
-
Haemostatic abnormalities in lung cancer: Prognostic implications
-
Buccheri G, Ferrigno D, Ginardi C, et al. Haemostatic abnormalities in lung cancer: prognostic implications. Eur J Cancer 1997; 33:50-55
-
(1997)
Eur J Cancer
, vol.33
, pp. 50-55
-
-
Buccheri, G.1
Ferrigno, D.2
Ginardi, C.3
-
66
-
-
9844224493
-
Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study
-
Groupe d'Oncologie de Langue Francaise
-
Jacoulet P, Depierre A, Moro D, et al. Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study; Groupe d'Oncologie de Langue Francaise. Ann Oncol 1997; 8:1009-1014
-
(1997)
Ann Oncol
, vol.8
, pp. 1009-1014
-
-
Jacoulet, P.1
Depierre, A.2
Moro, D.3
-
67
-
-
0030754024
-
Prognostic significance of plasma D-dimer levels in patients with lung cancer
-
Taguchi O, Gabazza EC, Yasui H, et al. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax 1997; 52:563-565
-
(1997)
Thorax
, vol.52
, pp. 563-565
-
-
Taguchi, O.1
Gabazza, E.C.2
Yasui, H.3
-
68
-
-
0026688455
-
Prognostic significance of blood coagulation tests in carcinoma of the lung and colon
-
Wojtukiewicz MZ, Zacharski LR, Moritz TE, et al. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Blood Coagul Fibrinolysis 1992; 3:429-437
-
(1992)
Blood Coagul Fibrinolysis
, vol.3
, pp. 429-437
-
-
Wojtukiewicz, M.Z.1
Zacharski, L.R.2
Moritz, T.E.3
-
69
-
-
10344231430
-
Prevalence and prognostic significance of proteinuria in patients with lung cancer
-
Pedersen LM, Milman N. Prevalence and prognostic significance of proteinuria in patients with lung cancer. Acta Oncol 1996; 35:691-695
-
(1996)
Acta Oncol
, vol.35
, pp. 691-695
-
-
Pedersen, L.M.1
Milman, N.2
-
70
-
-
0031892681
-
Depressive reactions to lung cancer are common and often followed by a poor outcome
-
Buccheri G. Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 1998; 11:173-178
-
(1998)
Eur Respir J
, vol.11
, pp. 173-178
-
-
Buccheri, G.1
-
71
-
-
0026325903
-
Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer
-
Miyamoto H, Harada M, Isobe H, et al. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer. Cancer Res 1991; 51:6346-6350
-
(1991)
Cancer Res
, vol.51
, pp. 6346-6350
-
-
Miyamoto, H.1
Harada, M.2
Isobe, H.3
-
72
-
-
0027440644
-
Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer
-
Pence JC, Kerns BJ, Dodge RK, et al. Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer. Arch Surg 1993; 128:1382-1390
-
(1993)
Arch Surg
, vol.128
, pp. 1382-1390
-
-
Pence, J.C.1
Kerns, B.J.2
Dodge, R.K.3
-
73
-
-
8044256501
-
Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer
-
Pifarre A, Rosell R, Monzo M, et al. Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer. Br J Cancer 1997; 75:184-189
-
(1997)
Br J Cancer
, vol.75
, pp. 184-189
-
-
Pifarre, A.1
Rosell, R.2
Monzo, M.3
-
74
-
-
0030760737
-
The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer
-
Kawasaki M, Nakanishi Y, Kuwano K, et al. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer. Clin Cancer Res 1997; 3:1195-1200
-
(1997)
Clin Cancer Res
, vol.3
, pp. 1195-1200
-
-
Kawasaki, M.1
Nakanishi, Y.2
Kuwano, K.3
-
75
-
-
0027300513
-
Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas
-
Volm M, Drings P, Wodrich W. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas. J Cancer Res Clin Oncol 1993; 119:507-510
-
(1993)
J Cancer Res Clin Oncol
, vol.119
, pp. 507-510
-
-
Volm, M.1
Drings, P.2
Wodrich, W.3
-
76
-
-
0027380337
-
Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer
-
Buccheri G, Ferrigno D, Vola F. Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer. Lung Cancer 1993; 10:21-33
-
(1993)
Lung Cancer
, vol.10
, pp. 21-33
-
-
Buccheri, G.1
Ferrigno, D.2
Vola, F.3
-
77
-
-
0027724642
-
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer
-
Carles J, Rosell R, Ariza A, et al. Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer. Lung Cancer 1993; 10:209-219
-
(1993)
Lung Cancer
, vol.10
, pp. 209-219
-
-
Carles, J.1
Rosell, R.2
Ariza, A.3
-
78
-
-
0027477568
-
Value of serum neuron-specific enolase in nonsmall cell lung cancer
-
Diez M, Torres A, Ortega L, et al. Value of serum neuron-specific enolase in nonsmall cell lung cancer. Oncology (Huntingt) 1993; 50:127-131
-
(1993)
Oncology (Huntingt)
, vol.50
, pp. 127-131
-
-
Diez, M.1
Torres, A.2
Ortega, L.3
-
79
-
-
0030930520
-
Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung carcinoma
-
Takekawa H, Takaoka K, Tsukamoto E, et al. Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung carcinoma. Cancer 1997; 80:198-203
-
(1997)
Cancer
, vol.80
, pp. 198-203
-
-
Takekawa, H.1
Takaoka, K.2
Tsukamoto, E.3
-
80
-
-
0026340550
-
Classification of lung cancer: First experiences with the new TNM classification (4th edition)
-
Bulzebruck H, Drings P, Kayser K, et al. Classification of lung cancer: first experiences with the new TNM classification (4th edition). Eur Respir J 1991; 4:1197-1206
-
(1991)
Eur Respir J
, vol.4
, pp. 1197-1206
-
-
Bulzebruck, H.1
Drings, P.2
Kayser, K.3
-
81
-
-
0030926263
-
Regional lymph node classification for lung cancer staging
-
Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111:1718-1723
-
(1997)
Chest
, vol.111
, pp. 1718-1723
-
-
Mountain, C.F.1
Dresler, C.M.2
-
82
-
-
0027729625
-
Analysis of prognostic factors in patients with resected peripheral T1 adenocarcinoma of the lung
-
Lima C, Matsui K, Kitagawa M, et al. Analysis of prognostic factors in patients with resected peripheral T1 adenocarcinoma of the lung. Pathol Res Pract 1993; 189:1149-1153
-
(1993)
Pathol Res Pract
, vol.189
, pp. 1149-1153
-
-
Lima, C.1
Matsui, K.2
Kitagawa, M.3
-
84
-
-
0028966055
-
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression
-
Harpole DHJ, Herndon JE, Wolfe WG, et al. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995; 55:51-56
-
(1995)
Cancer Res
, vol.55
, pp. 51-56
-
-
Harpole, D.H.J.1
Herndon, J.E.2
Wolfe, W.G.3
-
85
-
-
0028811996
-
Incidence of local recurrence and second primary tumors in resected stage I lung cancer
-
Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. Thorac Cardiovasc Surg 1995; 109:120-129
-
(1995)
Thorac Cardiovasc Surg
, vol.109
, pp. 120-129
-
-
Martini, N.1
Bains, M.S.2
Burt, M.E.3
-
86
-
-
0033557596
-
Five-year survivors with resected pN2 nonsmall cell lung carcinoma
-
Sagawa M, Sakurada A, Fujimura S, et al. Five-year survivors with resected pN2 nonsmall cell lung carcinoma. Cancer 1999; 85:864-868
-
(1999)
Cancer
, vol.85
, pp. 864-868
-
-
Sagawa, M.1
Sakurada, A.2
Fujimura, S.3
-
87
-
-
0031137302
-
Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases: Leuven Lung Cancer Group
-
Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases: Leuven Lung Cancer Group. Ann Thorac Surg 1997; 63:1441-1450
-
(1997)
Ann Thorac Surg
, vol.63
, pp. 1441-1450
-
-
Vansteenkiste, J.F.1
De Leyn, P.R.2
Deneffe, G.J.3
-
88
-
-
0031883133
-
"Incomplete resection" in non-small cell lung cancer: Need for a new definition
-
Canadian Lung Oncology Group
-
Lacasse Y, Bucher HC, Wong E, et al. "Incomplete resection" in non-small cell lung cancer: need for a new definition; Canadian Lung Oncology Group. Ann Thorac Surg 1998; 65:220-226
-
(1998)
Ann Thorac Surg
, vol.65
, pp. 220-226
-
-
Lacasse, Y.1
Bucher, H.C.2
Wong, E.3
-
89
-
-
0030694187
-
Relationship between vascularity, age and survival in non-small-cell lung cancer
-
Chandrachud LM, Pendleton N, Chisholm DM, et al. Relationship between vascularity, age and survival in non-small-cell lung cancer. Br J Cancer 1997; 76:1367-1375
-
(1997)
Br J Cancer
, vol.76
, pp. 1367-1375
-
-
Chandrachud, L.M.1
Pendleton, N.2
Chisholm, D.M.3
-
90
-
-
0030036146
-
"Tumour volume" as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)
-
Jefferson MF, Pendleton N, Faragher EB, et al. "Tumour volume" as a predictor of survival after resection of non-small-cell lung cancer (NSCLC). Br J Cancer 1996; 74:456-459
-
(1996)
Br J Cancer
, vol.74
, pp. 456-459
-
-
Jefferson, M.F.1
Pendleton, N.2
Faragher, E.B.3
-
91
-
-
0026727298
-
Lung cancer in young adults
-
Bourke W, Milstein D, Giura R, et al. Lung cancer in young adults. Chest 1992; 102:1723-1729
-
(1992)
Chest
, vol.102
, pp. 1723-1729
-
-
Bourke, W.1
Milstein, D.2
Giura, R.3
-
92
-
-
0029986344
-
Bronchogenic cancer in the elderly: Operative risk and long-term prognosis
-
Massard G, Moog R, Wihlm JM, et al. Bronchogenic cancer in the elderly: operative risk and long-term prognosis. Thorac Cardiovasc Surg 1996; 44:40-45
-
(1996)
Thorac Cardiovasc Surg
, vol.44
, pp. 40-45
-
-
Massard, G.1
Moog, R.2
Wihlm, J.M.3
-
93
-
-
0027248096
-
Prognostic significance of metastases to mediastinal lymph node levels in resected non-small cell lung carcinoma
-
Conill C, Astudillo J, Verger E. Prognostic significance of metastases to mediastinal lymph node levels in resected non-small cell lung carcinoma. Cancer 1993; 72:1199-1202
-
(1993)
Cancer
, vol.72
, pp. 1199-1202
-
-
Conill, C.1
Astudillo, J.2
Verger, E.3
-
94
-
-
0027762049
-
Prognostic significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer
-
Kondo H, Asamura H, Suemasu K, et al. Prognostic significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer. Thorac Cardiovasc Surg 1993; 106:1092-1097
-
(1993)
Thorac Cardiovasc Surg
, vol.106
, pp. 1092-1097
-
-
Kondo, H.1
Asamura, H.2
Suemasu, K.3
-
95
-
-
0030951621
-
The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer
-
Buhr J, Berghauser KH, Gonner S, et al. The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer. Thorac Cardiovasc Surg 1997; 113:683-690
-
(1997)
Thorac Cardiovasc Surg
, vol.113
, pp. 683-690
-
-
Buhr, J.1
Berghauser, K.H.2
Gonner, S.3
-
96
-
-
0030865353
-
Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer
-
Fukuse T, Hirata T, Tanaka F, et al. Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer. Eur J Cardiothorac Surg 1997; 12:218-223
-
(1997)
Eur J Cardiothorac Surg
, vol.12
, pp. 218-223
-
-
Fukuse, T.1
Hirata, T.2
Tanaka, F.3
-
97
-
-
0027301691
-
Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients
-
Ichinose Y, Hara N, Ohta M, et al. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients. Thorac Cardiovasc Surg 1993; 106:90-94
-
(1993)
Thorac Cardiovasc Surg
, vol.106
, pp. 90-94
-
-
Ichinose, Y.1
Hara, N.2
Ohta, M.3
-
98
-
-
0026029716
-
Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit
-
Sobue T, Suzuki T, Fujimoto I, et al. Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit. Jpn J Cancer Res 1991; 82:33-39
-
(1991)
Jpn J Cancer Res
, vol.82
, pp. 33-39
-
-
Sobue, T.1
Suzuki, T.2
Fujimoto, I.3
-
99
-
-
0032411362
-
Results after surgery in stage-I bronchogenic carcinoma
-
Wertzel H, Siebert H, Lange W, et al. Results after surgery in stage-I bronchogenic carcinoma. Thorac Cardiovasc Surg 1998; 46:365-369
-
(1998)
Thorac Cardiovasc Surg
, vol.46
, pp. 365-369
-
-
Wertzel, H.1
Siebert, H.2
Lange, W.3
-
100
-
-
9344265211
-
Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer
-
Diez M, Torres A, Maestro ML, et al. Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer. Br J Cancer 1996; 73:1248-1254
-
(1996)
Br J Cancer
, vol.73
, pp. 1248-1254
-
-
Diez, M.1
Torres, A.2
Maestro, M.L.3
-
101
-
-
0021231694
-
Prognostic factors in patients with resected stage I non-small cell lung cancer: A report from the Lung Cancer Study Group
-
Gail MH, Eagan RT, Feld R, et al. Prognostic factors in patients with resected stage I non-small cell lung cancer: a report from the Lung Cancer Study Group. Cancer 1984; 54:1802-1813
-
(1984)
Cancer
, vol.54
, pp. 1802-1813
-
-
Gail, M.H.1
Eagan, R.T.2
Feld, R.3
-
102
-
-
0022410638
-
The role of serum tumour markers to aid the selection of lung cancer patients for surgery and the assessment of prognosis
-
Muller T, Marshall RJ, Cooper EH, et al. The role of serum tumour markers to aid the selection of lung cancer patients for surgery and the assessment of prognosis. Eur J Cancer Clin Oncol 1985; 21:1461-1466
-
(1985)
Eur J Cancer Clin Oncol
, vol.21
, pp. 1461-1466
-
-
Muller, T.1
Marshall, R.J.2
Cooper, E.H.3
-
103
-
-
0021266417
-
Bronchial carcinoma: Factors influencing postoperative survival
-
Clee MD, Hockings NF, Johnston RN. Bronchial carcinoma: factors influencing postoperative survival. Br J Dis Chest 1984; 78:225-235
-
(1984)
Br J Dis Chest
, vol.78
, pp. 225-235
-
-
Clee, M.D.1
Hockings, N.F.2
Johnston, R.N.3
-
104
-
-
0027326034
-
Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer
-
Macchiarini P, Fontanini G, Hardin MJ, et al. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer. Thorac Cardiovasc Surg 1993; 106:80-89
-
(1993)
Thorac Cardiovasc Surg
, vol.106
, pp. 80-89
-
-
Macchiarini, P.1
Fontanini, G.2
Hardin, M.J.3
-
105
-
-
0029910834
-
Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: Correlation with TNM stage and disease free and overall survival
-
Brechot JM, Chevret S, Charpentier MC, et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: correlation with TNM stage and disease free and overall survival. Cancer 1996; 78:2111-2118
-
(1996)
Cancer
, vol.78
, pp. 2111-2118
-
-
Brechot, J.M.1
Chevret, S.2
Charpentier, M.C.3
-
106
-
-
0030296793
-
Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer
-
Kessler R, Gasser B, Massard G, et al. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg 1996; 62:1489-1493
-
(1996)
Ann Thorac Surg
, vol.62
, pp. 1489-1493
-
-
Kessler, R.1
Gasser, B.2
Massard, G.3
-
107
-
-
0031899930
-
Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer
-
Komaki R, Milas L, Ro JY, et al. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1998; 40:787-796
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.40
, pp. 787-796
-
-
Komaki, R.1
Milas, L.2
Ro, J.Y.3
-
108
-
-
0030271689
-
Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer
-
Komaki R, Fujii T, Perkins P, et al. Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1996; 36:601-605
-
(1996)
Int J Radiat Oncol Biol Phys
, vol.36
, pp. 601-605
-
-
Komaki, R.1
Fujii, T.2
Perkins, P.3
-
109
-
-
0031945469
-
Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer
-
Duarte IG, Bufkin BL, Pennington MF, et al. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. Thorac Cardiovasc Surg 1998; 115:652-658
-
(1998)
Thorac Cardiovasc Surg
, vol.115
, pp. 652-658
-
-
Duarte, I.G.1
Bufkin, B.L.2
Pennington, M.F.3
-
110
-
-
0030668890
-
Tumor angiogenesis and biologic markers in resected stage I NSCLC
-
Lucchi M, Fontanini G, Mussi A, et al. Tumor angiogenesis and biologic markers in resected stage I NSCLC. Eur J Cardiothorac Surg 1997; 12:535-541
-
(1997)
Eur J Cardiothorac Surg
, vol.12
, pp. 535-541
-
-
Lucchi, M.1
Fontanini, G.2
Mussi, A.3
-
111
-
-
0029933365
-
A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC)
-
Nestle U, Nieder C, Abel U, et al. A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC). Radiother Oncol 1996; 38:195-203
-
(1996)
Radiother Oncol
, vol.38
, pp. 195-203
-
-
Nestle, U.1
Nieder, C.2
Abel, U.3
-
112
-
-
0029891577
-
Recurrence and death in non-small cell lung carcinomas: A prognostic model using pathological parameters, microvessel count, and gene protein products
-
Fontanini G, Vignati S, Bigini D, et al. Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products. Clin Cancer Res 1996; 2:1067-1075
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1067-1075
-
-
Fontanini, G.1
Vignati, S.2
Bigini, D.3
-
113
-
-
0031907022
-
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: Amphiregulin and microvessel count are independent prognostic indicators of survival
-
Fontanini G, De Laurentiis M, Vignati S, et al. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res 1998; 4:241-249
-
(1998)
Clin Cancer Res
, vol.4
, pp. 241-249
-
-
Fontanini, G.1
De Laurentiis, M.2
Vignati, S.3
-
114
-
-
8244233169
-
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression
-
Fontanini G, Vignati S, Lucchi M, et al. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer 1997; 75:1295-1301
-
(1997)
Br J Cancer
, vol.75
, pp. 1295-1301
-
-
Fontanini, G.1
Vignati, S.2
Lucchi, M.3
-
115
-
-
0031398777
-
Tumor angiogenesis in pulmonary adenocarcinomas: Relationship with basic fibroblast growth factor, its receptor, and survival
-
Takanami I, Tanaka F, Hashizume T, et al. Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival. Neoplasma 1997; 44:295-298
-
(1997)
Neoplasma
, vol.44
, pp. 295-298
-
-
Takanami, I.1
Tanaka, F.2
Hashizume, T.3
-
116
-
-
0024530868
-
Morphometric and morphologic evaluations in stage III non-small cell lung cancers: Prognostic significance of quantitative assessment of infiltrating lymphoid cells
-
Lee TK, Horner RD, Silverman JF, et al. Morphometric and morphologic evaluations in stage III non-small cell lung cancers: prognostic significance of quantitative assessment of infiltrating lymphoid cells. Cancer 1989; 63:309-316
-
(1989)
Cancer
, vol.63
, pp. 309-316
-
-
Lee, T.K.1
Horner, R.D.2
Silverman, J.F.3
-
117
-
-
0025810303
-
Expression of blood-group antigen A: A favorable prognostic factor in non-small-cell lung cancer
-
Lee JS, Ro JY, Sahin AA, et al. Expression of blood-group antigen A: a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991; 324:1084-1090
-
(1991)
N Engl J Med
, vol.324
, pp. 1084-1090
-
-
Lee, J.S.1
Ro, J.Y.2
Sahin, A.A.3
-
118
-
-
0026734888
-
Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung
-
Miyake M, Taki T, Hitomi S, et al. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med 1992; 327:14-18
-
(1992)
N Engl J Med
, vol.327
, pp. 14-18
-
-
Miyake, M.1
Taki, T.2
Hitomi, S.3
-
119
-
-
0032433708
-
Lewis Y antigen expression and postoperative survival in non-small cell lung cancer
-
Tanaka F, Miyahara R, Ohtake Y, et al. Lewis Y antigen expression and postoperative survival in non-small cell lung cancer. Ann Thorac Surg 1998; 66:1745-1750
-
(1998)
Ann Thorac Surg
, vol.66
, pp. 1745-1750
-
-
Tanaka, F.1
Miyahara, R.2
Ohtake, Y.3
-
120
-
-
0031979703
-
Do molecular markers predict survival in non-small-cell lung cancer?
-
Greatens TM, Niehans GA, Rubins JB, et al. Do molecular markers predict survival in non-small-cell lung cancer? Am J Respir Crit Care Med 1998; 157:1093-1097
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 1093-1097
-
-
Greatens, T.M.1
Niehans, G.A.2
Rubins, J.B.3
-
121
-
-
0026019680
-
Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer
-
Jorgensen LG, Hirsch FR, Skov BG, et al. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer. Br J Cancer 1991; 63:151-153
-
(1991)
Br J Cancer
, vol.63
, pp. 151-153
-
-
Jorgensen, L.G.1
Hirsch, F.R.2
Skov, B.G.3
-
122
-
-
0029865287
-
Combined modality therapy of lung cancer and lung tolerance
-
Abratt RP. Combined modality therapy of lung cancer and lung tolerance. J Clin Oncol 1996; 14:1402-1403
-
(1996)
J Clin Oncol
, vol.14
, pp. 1402-1403
-
-
Abratt, R.P.1
-
123
-
-
0023225827
-
Use of carcinoembryonic antigen in small cell lung cancer: Prognostic value and relation to the clinical course 1
-
Laberge F, Fritsche HA, Umsawasdi T, et al. Use of carcinoembryonic antigen in small cell lung cancer: prognostic value and relation to the clinical course 1. Cancer 1987; 59:2047-2052
-
(1987)
Cancer
, vol.59
, pp. 2047-2052
-
-
Laberge, F.1
Fritsche, H.A.2
Umsawasdi, T.3
-
124
-
-
0021934125
-
Carcinoembryonic antigen: A useful prognostic marker in small-cell lung cancer
-
Sculier JP, Feld R, Evans WK, et al. Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer. J Clin Oncol 1985; 3:1349-1354
-
(1985)
J Clin Oncol
, vol.3
, pp. 1349-1354
-
-
Sculier, J.P.1
Feld, R.2
Evans, W.K.3
-
125
-
-
0026623488
-
Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lung
-
Carey FA, Prasad US, Walker WS, et al. Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lung. Thorac Cardiovasc Surg 1992; 103:1214-1217
-
(1992)
Thorac Cardiovasc Surg
, vol.103
, pp. 1214-1217
-
-
Carey, F.A.1
Prasad, U.S.2
Walker, W.S.3
-
126
-
-
0026010940
-
Postoperative adjuvant chemotherapy in non-small cell lung cancer: Prognostic value of DNA ploidy and post-recurrent survival
-
Ichinose Y, Hara N, Ohta M, et al. Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival. J Surg Oncol 1991; 46:15-20
-
(1991)
J Surg Oncol
, vol.46
, pp. 15-20
-
-
Ichinose, Y.1
Hara, N.2
Ohta, M.3
-
127
-
-
0023190493
-
Ploidy as a prognostic determinant in surgically treated lung cancer
-
Zimmerman PV, Hawson GA, Bint MH, et al. Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet 1987; 2:530-533
-
(1987)
Lancet
, vol.2
, pp. 530-533
-
-
Zimmerman, P.V.1
Hawson, G.A.2
Bint, M.H.3
-
128
-
-
0024435630
-
DNA flow cytometric studies of 66 human lung tumors analyzed before treatment: Prognostic implications
-
Salvati F, Teodori L, Gagliardi L, et al. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment: prognostic implications. Chest 1989; 96:1092-1098
-
(1989)
Chest
, vol.96
, pp. 1092-1098
-
-
Salvati, F.1
Teodori, L.2
Gagliardi, L.3
-
129
-
-
0025340655
-
DNA analysis by flow cytometry in nonsmall cell lung cancer: Relationship to epidermal growth factor receptor, histology, tumour stage and survival
-
Dazzi H, Thatcher N, Hasleton PS, et al. DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival. Respir Med 1990; 84:217-223
-
(1990)
Respir Med
, vol.84
, pp. 217-223
-
-
Dazzi, H.1
Thatcher, N.2
Hasleton, P.S.3
-
130
-
-
0027291490
-
Prognostic significance of flow cytometry in non-small-cell lung cancer
-
Rice TW, Bauer TW, Gephardt GN, et al. Prognostic significance of flow cytometry in non-small-cell lung cancer. Thorac Cardiovasc Surg 1993; 106:210-217
-
(1993)
Thorac Cardiovasc Surg
, vol.106
, pp. 210-217
-
-
Rice, T.W.1
Bauer, T.W.2
Gephardt, G.N.3
-
131
-
-
0023931379
-
Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer
-
Ten Velde GP, Schutte B, Vermeulen A, et al. Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer. Eur J Cancer Clin Oncol 1988; 24:455-460
-
(1988)
Eur J Cancer Clin Oncol
, vol.24
, pp. 455-460
-
-
Ten Velde, G.P.1
Schutte, B.2
Vermeulen, A.3
-
132
-
-
0024604666
-
The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung
-
Cibas ES, Melamed MR, Zaman MB, et al. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung. Cancer 1989; 63:1552-1556
-
(1989)
Cancer
, vol.63
, pp. 1552-1556
-
-
Cibas, E.S.1
Melamed, M.R.2
Zaman, M.B.3
-
133
-
-
0026611711
-
DNA content in correlation with postsurgical stage in non-small cell lung cancer
-
Carp NZ, Ellison DD, Brophy PF, et al. DNA content in correlation with postsurgical stage in non-small cell lung cancer. Ann Thorac Surg 1992; 53:680-683
-
(1992)
Ann Thorac Surg
, vol.53
, pp. 680-683
-
-
Carp, N.Z.1
Ellison, D.D.2
Brophy, P.F.3
-
134
-
-
0025633335
-
Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer
-
Ojala A, Kallioniemi OP, Wigren T, et al. Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer. Acta Oncol 1990; 29:983-988
-
(1990)
Acta Oncol
, vol.29
, pp. 983-988
-
-
Ojala, A.1
Kallioniemi, O.P.2
Wigren, T.3
-
135
-
-
0021924927
-
Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma
-
Volm M, Drings P, Mattern J, et al. Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer 1985; 56:1396-1403
-
(1985)
Cancer
, vol.56
, pp. 1396-1403
-
-
Volm, M.1
Drings, P.2
Mattern, J.3
-
136
-
-
0026601682
-
A flow cytometric study of non-small cell lung cancer classified as T1N0
-
Schmidt RA, Rusch VW, Piantadosi S. A flow cytometric study of non-small cell lung cancer classified as T1N0. Cancer 1992; 69:78-85
-
(1992)
Cancer
, vol.69
, pp. 78-85
-
-
Schmidt, R.A.1
Rusch, V.W.2
Piantadosi, S.3
-
137
-
-
1842377483
-
Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: Rationale of sequential processing of frozen and paraffin-embedded tissue
-
Muguerza JM, Diez M, Torres AJ, et al. Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: rationale of sequential processing of frozen and paraffin-embedded tissue. World J Surg 1997; 21:323-329
-
(1997)
World J Surg
, vol.21
, pp. 323-329
-
-
Muguerza, J.M.1
Diez, M.2
Torres, A.J.3
-
138
-
-
0030925368
-
Clinical and flow cytometric prognostic factors in surgically treated squamous cell lung cancer
-
Kolodziejski L, Niezabitowski A, Gasinska A. Clinical and flow cytometric prognostic factors in surgically treated squamous cell lung cancer. Lung Cancer 1997; 16:173-182
-
(1997)
Lung Cancer
, vol.16
, pp. 173-182
-
-
Kolodziejski, L.1
Niezabitowski, A.2
Gasinska, A.3
-
139
-
-
0023942513
-
Flow cytometry of epidermoid lung carcinomas: Relationship of ploidy and cell cycle phases to survival; a five-year follow up study
-
Volm M, Mattern J, Muller T, et al. Flow cytometry of epidermoid lung carcinomas: relationship of ploidy and cell cycle phases to survival; a five-year follow up study. Anticancer Res 1988; 8:105-112
-
(1988)
Anticancer Res
, vol.8
, pp. 105-112
-
-
Volm, M.1
Mattern, J.2
Muller, T.3
-
140
-
-
0023923335
-
Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma
-
Volm M, Hahn EW, Mattern J, et al. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res 1988; 48:2923-2928
-
(1988)
Cancer Res
, vol.48
, pp. 2923-2928
-
-
Volm, M.1
Hahn, E.W.2
Mattern, J.3
-
141
-
-
0024504303
-
The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up
-
van Bodegom PC, Baak JP, Stroet-van Galen C, et al. The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up. Cancer 1989; 63:143-147
-
(1989)
Cancer
, vol.63
, pp. 143-147
-
-
Van Bodegom, P.C.1
Baak, J.P.2
Stroet-van Galen, C.3
-
142
-
-
0027434477
-
Prognostic significance of Ki67 labelling in resected non small cell lung cancer
-
Scagliotti GV, Micela M, Gubetta L, et al. Prognostic significance of Ki67 labelling in resected non small cell lung cancer. Eur J Cancer 1993; 29A:363-365
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 363-365
-
-
Scagliotti, G.V.1
Micela, M.2
Gubetta, L.3
-
143
-
-
10144220641
-
Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers
-
Pujol JL, Simony J, Jolimoy G, et al. Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers. Br J Cancer 1996; 74:964-970
-
(1996)
Br J Cancer
, vol.74
, pp. 964-970
-
-
Pujol, J.L.1
Simony, J.2
Jolimoy, G.3
-
144
-
-
0027525116
-
Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients
-
Ishida T, Kaneko S, Akazawa K, et al. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Cancer Res 1993; 53:5000-5003
-
(1993)
Cancer Res
, vol.53
, pp. 5000-5003
-
-
Ishida, T.1
Kaneko, S.2
Akazawa, K.3
-
145
-
-
0027586355
-
Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer
-
Fujii M, Motoi M, Saeki H, et al. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer. Acta Med Okayama 1993; 47: 103-108
-
(1993)
Acta Med Okayama
, vol.47
, pp. 103-108
-
-
Fujii, M.1
Motoi, M.2
Saeki, H.3
-
146
-
-
0344193099
-
Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung
-
Bellotti M, Elsner B, Paez DL, et al. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung. Mod Pathol 1997; 10:1221-1227
-
(1997)
Mod Pathol
, vol.10
, pp. 1221-1227
-
-
Bellotti, M.1
Elsner, B.2
Paez, D.L.3
-
147
-
-
0031254556
-
Prognostic significance of argyrophilic nucleolar organizer region (Ag-NOR) in resected non-small cell lung cancer (NSCLC)
-
Rodrigues OR, Antonangelo L, Yagi N, et al. Prognostic significance of argyrophilic nucleolar organizer region (Ag-NOR) in resected non-small cell lung cancer (NSCLC). Jpn J Clin Oncol 1997; 27:298-304
-
(1997)
Jpn J Clin Oncol
, vol.27
, pp. 298-304
-
-
Rodrigues, O.R.1
Antonangelo, L.2
Yagi, N.3
-
148
-
-
0342547253
-
A prognostic model of survival in surgically resected squamous cell carcinoma of the lung using clinical, pathologic, and biologic markers
-
Bernardi FD, Antonangelo L, Beyruti R, et al. A prognostic model of survival in surgically resected squamous cell carcinoma of the lung using clinical, pathologic, and biologic markers. Mod Pathol 1997; 10:992-1000
-
(1997)
Mod Pathol
, vol.10
, pp. 992-1000
-
-
Bernardi, F.D.1
Antonangelo, L.2
Beyruti, R.3
-
149
-
-
8044259004
-
Morphometric evaluation of argyrophilic nucleolar organizer region is useful in predicting long-term survival in squamous cell carcinoma of the lung
-
Antonangelo L, Bernardi FD, Capelozzi VL, et al. Morphometric evaluation of argyrophilic nucleolar organizer region is useful in predicting long-term survival in squamous cell carcinoma of the lung. Chest 1997; 111:110-114
-
(1997)
Chest
, vol.111
, pp. 110-114
-
-
Antonangelo, L.1
Bernardi, F.D.2
Capelozzi, V.L.3
-
150
-
-
0025003045
-
Thymidine labelling index as prognostic factor in resected non-small cell lung cancer
-
Alama A, Costantini M, Repetto L, et al. Thymidine labelling index as prognostic factor in resected non-small cell lung cancer. Eur J Cancer 1990; 26:622-625
-
(1990)
Eur J Cancer
, vol.26
, pp. 622-625
-
-
Alama, A.1
Costantini, M.2
Repetto, L.3
-
151
-
-
0025877829
-
Could cell kinetics be a predictor of prognosis in non-small cell lung cancer?
-
Silvestrini R, Muscolino G, Costa A, et al. Could cell kinetics be a predictor of prognosis in non-small cell lung cancer? Lung Cancer 1991; 7:165-170
-
(1991)
Lung Cancer
, vol.7
, pp. 165-170
-
-
Silvestrini, R.1
Muscolino, G.2
Costa, A.3
-
152
-
-
0032990377
-
Basal cell carcinoma with lung metastasis diagnosed by fine-needle aspiration biopsy
-
Patel MS, Thigpen JT, Vance RB, et al. Basal cell carcinoma with lung metastasis diagnosed by fine-needle aspiration biopsy. South Med J 1999; 92:321-324
-
(1999)
South Med J
, vol.92
, pp. 321-324
-
-
Patel, M.S.1
Thigpen, J.T.2
Vance, R.B.3
-
153
-
-
0032521183
-
Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor
-
Hirata T, Fukuse T, Naiki H, et al. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Cancer Res 1998; 58:1108-1110
-
(1998)
Cancer Res
, vol.58
, pp. 1108-1110
-
-
Hirata, T.1
Fukuse, T.2
Naiki, H.3
-
154
-
-
0031950315
-
Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer
-
Pantel K, Passlick B, Vogt J, et al. Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol 1998; 16:1407-1413
-
(1998)
J Clin Oncol
, vol.16
, pp. 1407-1413
-
-
Pantel, K.1
Passlick, B.2
Vogt, J.3
-
155
-
-
0025074419
-
K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
-
Slebos RJ, Kibbelaar RE, Dalesio O, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323:561-565
-
(1990)
N Engl J Med
, vol.323
, pp. 561-565
-
-
Slebos, R.J.1
Kibbelaar, R.E.2
Dalesio, O.3
-
156
-
-
0026680448
-
Clinical significance of ras oncogene activation in human lung cancer
-
Rodenhuis S, Slebos RJ. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 1992; 52:2665s-2669s
-
(1992)
Cancer Res
, vol.52
, pp. 2665s-2669s
-
-
Rodenhuis, S.1
Slebos, R.J.2
-
157
-
-
0026425629
-
ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent
-
Mitsudomi T, Steinberg SM, Oie HK, et al. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res 1991; 51:4999-5002
-
(1991)
Cancer Res
, vol.51
, pp. 4999-5002
-
-
Mitsudomi, T.1
Steinberg, S.M.2
Oie, H.K.3
-
158
-
-
0026533937
-
Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer
-
Harada M, Dosaka-Akita H, Miyamoto H, et al. Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer. Cancer 1992; 69:72-77
-
(1992)
Cancer
, vol.69
, pp. 72-77
-
-
Harada, M.1
Dosaka-Akita, H.2
Miyamoto, H.3
-
159
-
-
0027293578
-
The value of quality of life scores in clinical cancer research
-
Selby P. The value of quality of life scores in clinical cancer research. Eur J Cancer 1993; 29A:1656-1657
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 1656-1657
-
-
Selby, P.1
-
160
-
-
0031922727
-
Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung
-
Nemunaitis J, Klemow S, Tong A, et al. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung. Am J Clin Oncol 1998; 21:155-160
-
(1998)
Am J Clin Oncol
, vol.21
, pp. 155-160
-
-
Nemunaitis, J.1
Klemow, S.2
Tong, A.3
-
161
-
-
0031908238
-
Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer
-
Huang CL, Taki T, Adachi M, et al. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer. Int J Oncol 1998; 12:553-563
-
(1998)
Int J Oncol
, vol.12
, pp. 553-563
-
-
Huang, C.L.1
Taki, T.2
Adachi, M.3
-
162
-
-
0010973499
-
Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma
-
Cho JY, Kim JH, Lee YH, et al. Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma. Cancer 1997; 79:462-467
-
(1997)
Cancer
, vol.79
, pp. 462-467
-
-
Cho, J.Y.1
Kim, J.H.2
Lee, Y.H.3
-
163
-
-
0026654238
-
ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis
-
Sugio K, Ishida T, Yokoyama H, et al. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 1992; 52:2903-2906
-
(1992)
Cancer Res
, vol.52
, pp. 2903-2906
-
-
Sugio, K.1
Ishida, T.2
Yokoyama, H.3
-
164
-
-
0027473475
-
Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer
-
Horio Y, Takahashi T, Kuroishi T, et al. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res 1993; 53:1-4
-
(1993)
Cancer Res
, vol.53
, pp. 1-4
-
-
Horio, Y.1
Takahashi, T.2
Kuroishi, T.3
-
165
-
-
0026737950
-
Accumulation of p53 protein correlates with a poor prognosis in human lung cancer
-
Quinlan DC, Davidson AG, Summers CL, et al. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 1992; 52:4828-4831
-
(1992)
Cancer Res
, vol.52
, pp. 4828-4831
-
-
Quinlan, D.C.1
Davidson, A.G.2
Summers, C.L.3
-
166
-
-
0027197426
-
Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas
-
Morkve O, Halvorsen OJ, Skjaerven R, et al. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas. Anticancer Res 1993; 13:571-578
-
(1993)
Anticancer Res
, vol.13
, pp. 571-578
-
-
Morkve, O.1
Halvorsen, O.J.2
Skjaerven, R.3
-
167
-
-
0027137816
-
Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer
-
Mitsudomi T, Oyama T, Kusano T, et al. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J Natl Cancer Inst 1993; 85: 2018-2023
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 2018-2023
-
-
Mitsudomi, T.1
Oyama, T.2
Kusano, T.3
-
168
-
-
0032516210
-
Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer
-
Huang C, Taki T, Adachi M, et al. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Oncogene 1998; 16:2469-2477
-
(1998)
Oncogene
, vol.16
, pp. 2469-2477
-
-
Huang, C.1
Taki, T.2
Adachi, M.3
-
169
-
-
8244225811
-
p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer
-
Vega FJ, Iniesta P, Caldes T, et al. p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer. Br J Cancer 1997; 76:44-51
-
(1997)
Br J Cancer
, vol.76
, pp. 44-51
-
-
Vega, F.J.1
Iniesta, P.2
Caldes, T.3
-
170
-
-
9044231367
-
Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers
-
Nishio M, Koshikawa T, Kuroishi T, et al. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. J Clin Oncol 1996; 14:497-502
-
(1996)
J Clin Oncol
, vol.14
, pp. 497-502
-
-
Nishio, M.1
Koshikawa, T.2
Kuroishi, T.3
-
171
-
-
9844241593
-
DNA aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma
-
Dalquen P, Moch H, Feichter G, et al. DNA aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma. Virchows Arch 1997; 431: 173-179
-
(1997)
Virchows Arch
, vol.431
, pp. 173-179
-
-
Dalquen, P.1
Moch, H.2
Feichter, G.3
-
172
-
-
0030989021
-
Altered retinoblastoma protein expression in nonsmall cell lung cancer: Its synergistic effects with altered ras and p53 protein status on prognosis
-
Dosaka-Akita H, Hu SX, Fujino M, et al. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer 1997; 79:1329-1337
-
(1997)
Cancer
, vol.79
, pp. 1329-1337
-
-
Dosaka-Akita, H.1
Hu, S.X.2
Fujino, M.3
-
173
-
-
0030747031
-
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung
-
Komiya T, Hosono Y, Hirashima T, et al. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung. Clin Cancer Res 1997; 3:1831-1835
-
(1997)
Clin Cancer Res
, vol.3
, pp. 1831-1835
-
-
Komiya, T.1
Hosono, Y.2
Hirashima, T.3
-
174
-
-
0031049786
-
bcl-2 oncoprotein in surgically resected non-small cell lung cancer: Possibly favorable prognostic factor in association with low incidence of distant metastasis
-
Higashiyama M, Doi O, Kodama K, et al. bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis. J Surg Oncol 1997; 64:48-54
-
(1997)
J Surg Oncol
, vol.64
, pp. 48-54
-
-
Higashiyama, M.1
Doi, O.2
Kodama, K.3
-
175
-
-
0030940210
-
Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer
-
Apolinario RM, van der Valk P, de Jong JS, et al. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol 1997; 15:2456-2466
-
(1997)
J Clin Oncol
, vol.15
, pp. 2456-2466
-
-
Apolinario, R.M.1
Van der Valk, P.2
De Jong, J.S.3
-
176
-
-
0031963988
-
Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas
-
Volm M, Rittgen W, Drings P. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br J Cancer 1998; 77:663-669
-
(1998)
Br J Cancer
, vol.77
, pp. 663-669
-
-
Volm, M.1
Rittgen, W.2
Drings, P.3
-
177
-
-
0029789878
-
Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
-
Ebert W, Muley T, Drings P. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Res 1996; 16:2161-2168
-
(1996)
Anticancer Res
, vol.16
, pp. 2161-2168
-
-
Ebert, W.1
Muley, T.2
Drings, P.3
-
178
-
-
0029997283
-
Prognostic value of MIB-1 in neuroendocrine tumours of the lung
-
Bohm J, Koch S, Gais P, et al. Prognostic value of MIB-1 in neuroendocrine tumours of the lung. J Pathol 1996; 178: 402-409
-
(1996)
J Pathol
, vol.178
, pp. 402-409
-
-
Bohm, J.1
Koch, S.2
Gais, P.3
-
179
-
-
0029818514
-
Cytokeratins as serum markers in lung cancer: A comparison of CYFRA 21-1 and TPS
-
Pujol JL, Grenier J, Parrat E, et al. Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS. Am J Respir Crit Care Med 1996; 154:725-733
-
(1996)
Am J Respir Crit Care Med
, vol.154
, pp. 725-733
-
-
Pujol, J.L.1
Grenier, J.2
Parrat, E.3
-
180
-
-
0030043947
-
Lung cancer chemotherapy: Response-survival relationship depends on the method of chest tumor response evaluation
-
Pujol JL, Parrat E, Lehmann M, et al. Lung cancer chemotherapy: response-survival relationship depends on the method of chest tumor response evaluation. Am J Respir Crit Care Med 1996; 153:243-249
-
(1996)
Am J Respir Crit Care Med
, vol.153
, pp. 243-249
-
-
Pujol, J.L.1
Parrat, E.2
Lehmann, M.3
-
181
-
-
0032421718
-
Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer
-
Niklinski J, Burzykowski T, Niklinska W, et al. Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer. Eur Respir J 1998; 12:1424-1428
-
(1998)
Eur Respir J
, vol.12
, pp. 1424-1428
-
-
Niklinski, J.1
Burzykowski, T.2
Niklinska, W.3
-
182
-
-
0032423812
-
Prognostic significance of CYFRA 21-1 in non-small cell lung cancer
-
Hirashima T, Takada M, Komiya T, et al. Prognostic significance of CYFRA 21-1 in non-small cell lung cancer. Anticancer Res 1998; 18:4713- 4716
-
(1998)
Anticancer Res
, vol.18
, pp. 4713-4716
-
-
Hirashima, T.1
Takada, M.2
Komiya, T.3
-
183
-
-
0032525120
-
Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: Does the combined use of cytokeratin markers give any additional information?
-
Nisman B, Lafair J, Heching N, et al. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell
-
(1998)
Cancer
, vol.82
, pp. 1850-1859
-
-
Nisman, B.1
Lafair, J.2
Heching, N.3
-
184
-
-
0031105977
-
Diagnostic and prognostic value of CYFRA 21-1 compared with other tumour markers in patients with non-small cell lung cancer: A prospective study of 116 patients
-
Brechot JM, Chevret S, Nataf J, et al. Diagnostic and prognostic value of CYFRA 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients. Eur J Cancer 1997; 33:385-391
-
(1997)
Eur J Cancer
, vol.33
, pp. 385-391
-
-
Brechot, J.M.1
Chevret, S.2
Nataf, J.3
-
185
-
-
0031923869
-
Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression
-
Adachi M, Taki T, Konishi T, et al. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression. J Clin Oncol 1998; 16: 1397-1406
-
(1998)
J Clin Oncol
, vol.16
, pp. 1397-1406
-
-
Adachi, M.1
Taki, T.2
Konishi, T.3
-
186
-
-
0030972183
-
Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis
-
Higashiyama M, Doi O, Kodama K, et al. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Int J Cancer 1997; 74:205-211
-
(1997)
Int J Cancer
, vol.74
, pp. 205-211
-
-
Higashiyama, M.1
Doi, O.2
Kodama, K.3
-
187
-
-
0029932247
-
Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer
-
Adachi M, Taki T, Ieki Y, et al. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996; 56:1751-1755
-
(1996)
Cancer Res
, vol.56
, pp. 1751-1755
-
-
Adachi, M.1
Taki, T.2
Ieki, Y.3
-
188
-
-
0027232422
-
The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
-
Veale D, Kerr N, Gibson GJ, et al. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br J Cancer 1993; 68:162-165
-
(1993)
Br J Cancer
, vol.68
, pp. 162-165
-
-
Veale, D.1
Kerr, N.2
Gibson, G.J.3
-
189
-
-
0025952816
-
Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma
-
Tateishi M, Ishida T, Mitsudomi T, et al. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 1991; 27:1372-1375
-
(1991)
Eur J Cancer
, vol.27
, pp. 1372-1375
-
-
Tateishi, M.1
Ishida, T.2
Mitsudomi, T.3
-
190
-
-
0025708183
-
p185neu expression in human lung adenocarcinomas predicts shortened survival
-
Kern JA, Schwartz DA, Nordberg JE, et al. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 1990; 50:5184-5187
-
(1990)
Cancer Res
, vol.50
, pp. 5184-5187
-
-
Kern, J.A.1
Schwartz, D.A.2
Nordberg, J.E.3
-
191
-
-
0029790384
-
Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: An evaluation of their expression as prognostic markers
-
Takanami I, Tanana F, Hashizume T, et al. Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers. Oncology (Huntingt) 1996; 53:392-397
-
(1996)
Oncology (Huntingt)
, vol.53
, pp. 392-397
-
-
Takanami, I.1
Tanana, F.2
Hashizume, T.3
-
192
-
-
0031057905
-
Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer
-
Siegfried JM, Weissfeld LA, Singh-Kaw P, et al. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res 1997; 57:433-439
-
(1997)
Cancer Res
, vol.57
, pp. 433-439
-
-
Siegfried, J.M.1
Weissfeld, L.A.2
Singh-Kaw, P.3
-
193
-
-
0030969559
-
Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma
-
Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 1997; 3:861-865
-
(1997)
Clin Cancer Res
, vol.3
, pp. 861-865
-
-
Fontanini, G.1
Vignati, S.2
Boldrini, L.3
-
194
-
-
0025793697
-
Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma
-
Kibbelaar RE, Moolenaar KE, Michalides RJ, et al. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer 1991; 27:431-435
-
(1991)
Eur J Cancer
, vol.27
, pp. 431-435
-
-
Kibbelaar, R.E.1
Moolenaar, K.E.2
Michalides, R.J.3
-
195
-
-
0026558234
-
Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma
-
Tisi E, Lissoni P, Angeli M, et al. Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma. Cancer 1992; 69:2458-2462
-
(1992)
Cancer
, vol.69
, pp. 2458-2462
-
-
Tisi, E.1
Lissoni, P.2
Angeli, M.3
-
196
-
-
0030794029
-
Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers
-
Nishio M, Koshikawa T, Yatabe Y, et al. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res 1997; 3:1051-1058
-
(1997)
Clin Cancer Res
, vol.3
, pp. 1051-1058
-
-
Nishio, M.1
Koshikawa, T.2
Yatabe, Y.3
-
197
-
-
0030043970
-
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer
-
Betticher DC, Heighway J, Hasleton PS, et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 1996; 73:294-300
-
(1996)
Br J Cancer
, vol.73
, pp. 294-300
-
-
Betticher, D.C.1
Heighway, J.2
Hasleton, P.S.3
-
198
-
-
0030809321
-
Prognostic role of cyclin D1 in non small cell lung cancer: An immunohistochemical analysis
-
Caputi M, De Luca L, Papaccio G, et al. Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis. Eur J Histochem 1997; 41:133-138
-
(1997)
Eur J Histochem
, vol.41
, pp. 133-138
-
-
Caputi, M.1
De Luca, L.2
Papaccio, G.3
-
199
-
-
0030920937
-
Influence of cathepsin D expression in lung adenocarcinoma on prognosis: Possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells
-
Higashiyama M, Doi O, Kodama K, et al. Influence of cathepsin D expression in lung adenocarcinoma on prognosis: possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells. J Surg Oncol 1997; 65:10-19
-
(1997)
J Surg Oncol
, vol.65
, pp. 10-19
-
-
Higashiyama, M.1
Doi, O.2
Kodama, K.3
-
200
-
-
0025897013
-
Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung
-
Ten Velde GP, Havenith MG, Volovics A, et al. Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung. Cancer 1991; 67: 3001-3005
-
(1991)
Cancer
, vol.67
, pp. 3001-3005
-
-
Ten Velde, G.P.1
Havenith, M.G.2
Volovics, A.3
-
201
-
-
0026639138
-
Significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small-cell lung cancers
-
Pena CM, Rice TW, Ahmad M, et al. Significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small-cell lung cancers. Chest 1992; 102:84-88
-
(1992)
Chest
, vol.102
, pp. 84-88
-
-
Pena, C.M.1
Rice, T.W.2
Ahmad, M.3
-
202
-
-
0027325871
-
Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer
-
van Klaveren RJ, Festen J, Otten HJ, et al. Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer. Ann Thorac Surg 1993; 56:300-304
-
(1993)
Ann Thorac Surg
, vol.56
, pp. 300-304
-
-
Van Klaveren, R.J.1
Festen, J.2
Otten, H.J.3
-
203
-
-
0027305459
-
Expression of carbohydrate antigens in human pulmonary adenocarcinoma
-
Kawai T, Suzuki M, Kase K, et al. Expression of carbohydrate antigens in human pulmonary adenocarcinoma. Cancer 1993; 72:1581-1587
-
(1993)
Cancer
, vol.72
, pp. 1581-1587
-
-
Kawai, T.1
Suzuki, M.2
Kase, K.3
-
204
-
-
0028884881
-
Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer
-
Fujino M, Dosaka-Akita H, Harada M, et al. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer. Cancer 1995; 76:2457-2463
-
(1995)
Cancer
, vol.76
, pp. 2457-2463
-
-
Fujino, M.1
Dosaka-Akita, H.2
Harada, M.3
-
205
-
-
0030033010
-
p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: Relation to prognosis
-
Pappot H, Francis D, Brunner N, et al. p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis. Clin Cancer Res 1996; 2:155-160
-
(1996)
Clin Cancer Res
, vol.2
, pp. 155-160
-
-
Pappot, H.1
Francis, D.2
Brunner, N.3
-
206
-
-
0029889028
-
Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication
-
Mitsudomi T, Oyama T, Nishida K, et al. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication. Clin Cancer Res 1996; 2:1185-1189
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1185-1189
-
-
Mitsudomi, T.1
Oyama, T.2
Nishida, K.3
-
207
-
-
13244300654
-
Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma
-
Dalquen P, Sauter G, Torhorst J, et al. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. J Pathol 1996; 178:53-58
-
(1996)
J Pathol
, vol.178
, pp. 53-58
-
-
Dalquen, P.1
Sauter, G.2
Torhorst, J.3
-
208
-
-
0030009321
-
Insulin-like growth factor-II as a prognostic factor in pulmonary adenocarcinoma
-
Takanami I, Imamuma T, Hashizume T, et al. Insulin-like growth factor-II as a prognostic factor in pulmonary adenocarcinoma. J Surg Oncol 1996; 61:205-208
-
(1996)
J Surg Oncol
, vol.61
, pp. 205-208
-
-
Takanami, I.1
Imamuma, T.2
Hashizume, T.3
-
209
-
-
0031051964
-
Transforming growth factor-beta isoforms expressions in pulmonary adenocarcinomas as prognostic markers: An immunohistological study of one hundred and twenty patients
-
Takanami I, Tanaka F, Hashizume T, et al. Transforming growth factor-beta isoforms expressions in pulmonary adenocarcinomas as prognostic markers: an immunohistological study of one hundred and twenty patients. Oncology (Huntingt) 1997; 54:122-128
-
(1997)
Oncology (Huntingt)
, vol.54
, pp. 122-128
-
-
Takanami, I.1
Tanaka, F.2
Hashizume, T.3
-
210
-
-
0030993406
-
Selection mechanisms as major determinants of survival after pulmonary metastasectomy
-
Aberg T. Selection mechanisms as major determinants of survival after pulmonary metastasectomy. Ann Thorac Surg 1997; 63:611-612
-
(1997)
Ann Thorac Surg
, vol.63
, pp. 611-612
-
-
Aberg, T.1
-
211
-
-
0031041776
-
Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer
-
Graziano SL, Tatum AH, Gonchoroff NJ, et al. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer. Clin Cancer Res 1997; 3:87-93
-
(1997)
Clin Cancer Res
, vol.3
, pp. 87-93
-
-
Graziano, S.L.1
Tatum, A.H.2
Gonchoroff, N.J.3
-
212
-
-
0031037304
-
Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung
-
Fujisawa T, Yamaguchi Y. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung. Cancer 1997; 79:474-481
-
(1997)
Cancer
, vol.79
, pp. 474-481
-
-
Fujisawa, T.1
Yamaguchi, Y.2
-
213
-
-
0031467589
-
Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung
-
Komiya T, Hirashima T, Takada M, et al. Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung. Anticancer Res 1997; 17:3721-3724
-
(1997)
Anticancer Res
, vol.17
, pp. 3721-3724
-
-
Komiya, T.1
Hirashima, T.2
Takada, M.3
-
214
-
-
0031594754
-
Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung
-
Adachi M, Taki T, Huang C, et al. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J Clin Oncol 1998; 16:1060-1067
-
(1998)
J Clin Oncol
, vol.16
, pp. 1060-1067
-
-
Adachi, M.1
Taki, T.2
Huang, C.3
-
215
-
-
0032858245
-
Prognostic significance of apoptotic index in completely resected non-small-cell lung cancer
-
Tanaka F, Kawano Y, Li M, et al. Prognostic significance of apoptotic index in completely resected non-small-cell lung cancer. J Clin Oncol 1999; 17:2728-2736
-
(1999)
J Clin Oncol
, vol.17
, pp. 2728-2736
-
-
Tanaka, F.1
Kawano, Y.2
Li, M.3
-
216
-
-
0032888251
-
Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases
-
Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. J Clin Oncol 1999; 17:3201-3206
-
(1999)
J Clin Oncol
, vol.17
, pp. 3201-3206
-
-
Vansteenkiste, J.F.1
Stroobants, S.G.2
Dupont, P.J.3
-
217
-
-
0033570968
-
Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma: A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses
-
Suzuki K, Nagai K, Yoshida J, et al. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma: a comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer 1999; 86:1976-1984
-
(1999)
Cancer
, vol.86
, pp. 1976-1984
-
-
Suzuki, K.1
Nagai, K.2
Yoshida, J.3
-
218
-
-
0033498902
-
Prognostic impact of telomerase activity in non-small cell lung cancers
-
Taga S, Osaki T, Ohgami A, et al. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann Surg 1999; 230:715-720
-
(1999)
Ann Surg
, vol.230
, pp. 715-720
-
-
Taga, S.1
Osaki, T.2
Ohgami, A.3
-
219
-
-
0032743861
-
Non-small cell lung cancer: Prognostic factors in patients treated with surgery and postoperative radiation therapy
-
Lee JH, Machtay M, Kaiser LR, et al. Non-small cell lung cancer: prognostic factors in patients treated with surgery and postoperative radiation therapy. Radiology 1999; 213: 845-852
-
(1999)
Radiology
, vol.213
, pp. 845-852
-
-
Lee, J.H.1
Machtay, M.2
Kaiser, L.R.3
-
220
-
-
0033485503
-
Implications and prognostic value of K-ras mutation for early-stage lung cancer in women
-
Nelson HH, Christiani DC, Mark EJ, et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999; 91:2032-2038
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 2032-2038
-
-
Nelson, H.H.1
Christiani, D.C.2
Mark, E.J.3
-
221
-
-
0033229836
-
p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas
-
Hashimoto T, Tokuchi Y, Hayashi M, et al. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Cancer Res 1999; 59:5572-5577
-
(1999)
Cancer Res
, vol.59
, pp. 5572-5577
-
-
Hashimoto, T.1
Tokuchi, Y.2
Hayashi, M.3
-
222
-
-
0032886024
-
Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers
-
Hommura F, Dosaka-Akita H, Kinoshita I, et al. Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers. Br J Cancer 1999; 81:696-701
-
(1999)
Br J Cancer
, vol.81
, pp. 696-701
-
-
Hommura, F.1
Dosaka-Akita, H.2
Kinoshita, I.3
-
223
-
-
0032872258
-
Immunochemical analysis of cathepsin B in lung tumours: An independent prognostic factor for squamous cell carcinoma patients
-
Werle B, Lotterle H, Schanzenbacher U, et al. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients. Br J Cancer 1999; 81:510-519
-
(1999)
Br J Cancer
, vol.81
, pp. 510-519
-
-
Werle, B.1
Lotterle, H.2
Schanzenbacher, U.3
-
224
-
-
0032886757
-
Independent prognostic role of p16 expression in lung cancer
-
Groeger AM, Caputi M, Esposito V, et al. Independent prognostic role of p16 expression in lung cancer. Thorac Cardiovasc Surg 1999; 118:529-535
-
(1999)
Thorac Cardiovasc Surg
, vol.118
, pp. 529-535
-
-
Groeger, A.M.1
Caputi, M.2
Esposito, V.3
-
225
-
-
0032818807
-
Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: Implications related to the design of clinical trials
-
Sawyer TE, Bonner JA, Gould PM, et al. Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: implications related to the design of clinical trials. Int J Radiat Oncol Biol Phys 1999; 45:315-321
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.45
, pp. 315-321
-
-
Sawyer, T.E.1
Bonner, J.A.2
Gould, P.M.3
-
226
-
-
0032758942
-
Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis
-
Okada M, Tsubota N, Yoshimura M, et al. Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis. Ann Thorac Surg 1999; 68:326-330
-
(1999)
Ann Thorac Surg
, vol.68
, pp. 326-330
-
-
Okada, M.1
Tsubota, N.2
Yoshimura, M.3
-
227
-
-
0032928142
-
Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer
-
Kubuschok B, Passlick B, Izbicki JR, et al. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 1999; 17:19-24
-
(1999)
J Clin Oncol
, vol.17
, pp. 19-24
-
-
Kubuschok, B.1
Passlick, B.2
Izbicki, J.R.3
-
228
-
-
0033002559
-
Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer
-
Foa P, Fornier M, Miceli R, et al. Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer. Int J Biol Markers 1999; 14:92-98
-
(1999)
Int J Biol Markers
, vol.14
, pp. 92-98
-
-
Foa, P.1
Fornier, M.2
Miceli, R.3
-
229
-
-
0032900873
-
Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma
-
Tomizawa Y, Adachi J, Kohno T, et al. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma. Clin Cancer Res 1999; 5:1139-1146
-
(1999)
Clin Cancer Res
, vol.5
, pp. 1139-1146
-
-
Tomizawa, Y.1
Adachi, J.2
Kohno, T.3
-
230
-
-
0032779721
-
Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases
-
Yoshino I, Nakanishi R, Osaki T, et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest 1999; 116:144-149
-
(1999)
Chest
, vol.116
, pp. 144-149
-
-
Yoshino, I.1
Nakanishi, R.2
Osaki, T.3
-
231
-
-
0032991727
-
The prognosis of surgically resected N2 non-small cell lung cancer: The importance of clinical N status
-
Suzuki K, Nagai K, Yoshida J, et al. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. Thorac Cardiovasc Surg 1999; 118:145-153
-
(1999)
Thorac Cardiovasc Surg
, vol.118
, pp. 145-153
-
-
Suzuki, K.1
Nagai, K.2
Yoshida, J.3
-
232
-
-
0032937689
-
p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer
-
Tanaka F, Yanagihara K, Ohtake Y, et al. p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer. Jpn J Cancer Res 1999; 90:432-438
-
(1999)
Jpn J Cancer Res
, vol.90
, pp. 432-438
-
-
Tanaka, F.1
Yanagihara, K.2
Ohtake, Y.3
-
233
-
-
0033163313
-
Prognostic significance of different biomarkers in non-small cell lung cancer
-
Lavezzi AM, Santambrogio L, Bellaviti N, et al. Prognostic significance of different biomarkers in non-small cell lung cancer. Oncol Rep 1999; 6:819-825
-
(1999)
Oncol Rep
, vol.6
, pp. 819-825
-
-
Lavezzi, A.M.1
Santambrogio, L.2
Bellaviti, N.3
-
234
-
-
0033015810
-
Study of prognostic predictors for non-small cell lung cancer
-
Fu XL, Zhu XZ, Shi DR, et al. Study of prognostic predictors for non-small cell lung cancer. Lung Cancer 1999; 23:143-152
-
(1999)
Lung Cancer
, vol.23
, pp. 143-152
-
-
Fu, X.L.1
Zhu, X.Z.2
Shi, D.R.3
-
235
-
-
0033535615
-
A novel molecular staging protocol for non-small cell lung cancer
-
Miyake M, Adachi M, Huang C, et al. A novel molecular staging protocol for non-small cell lung cancer. Oncogene 1999; 18:2397-2404
-
(1999)
Oncogene
, vol.18
, pp. 2397-2404
-
-
Miyake, M.1
Adachi, M.2
Huang, C.3
-
236
-
-
0032915390
-
Relation between the serum E-selectin level and the survival rate of patients with resected non-small cell lung cancers
-
Tsumatori G, Ozeki Y, Takagi K, et al. Relation between the serum E-selectin level and the survival rate of patients with resected non-small cell lung cancers. Jpn J Cancer Res 1999; 90:301-307
-
(1999)
Jpn J Cancer Res
, vol.90
, pp. 301-307
-
-
Tsumatori, G.1
Ozeki, Y.2
Takagi, K.3
-
237
-
-
0032949196
-
Expression of bcl-2 protein in non-small cell lung cancer: Correlation with clinicopathology and patient survival
-
Laudanski J, Chyczewski L, Niklinska WE, et al. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival. Neoplasma 1999; 46:25-30
-
(1999)
Neoplasma
, vol.46
, pp. 25-30
-
-
Laudanski, J.1
Chyczewski, L.2
Niklinska, W.E.3
-
238
-
-
0344915156
-
Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance
-
Koomagi R, Volm M. Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Int J Cancer 1999; 84:239-243
-
(1999)
Int J Cancer
, vol.84
, pp. 239-243
-
-
Koomagi, R.1
Volm, M.2
-
239
-
-
0032970313
-
Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma
-
Puglisi F, Barbone F, Damante G, et al. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Mod Pathol 1999; 12:318-324
-
(1999)
Mod Pathol
, vol.12
, pp. 318-324
-
-
Puglisi, F.1
Barbone, F.2
Damante, G.3
-
240
-
-
0032915271
-
Prognostic factors in clinical stage I non-small cell lung cancer
-
Suzuki K, Nagai K, Yoshida J, et al. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999; 67:927-932
-
(1999)
Ann Thorac Surg
, vol.67
, pp. 927-932
-
-
Suzuki, K.1
Nagai, K.2
Yoshida, J.3
-
241
-
-
0032766423
-
Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer
-
Marchetti A, Bertacca G, Buttitta F, et al. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin Cancer Res 1999; 5:2077-2081
-
(1999)
Clin Cancer Res
, vol.5
, pp. 2077-2081
-
-
Marchetti, A.1
Bertacca, G.2
Buttitta, F.3
-
242
-
-
0033455515
-
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer
-
Nisman B, Amir G, Lafair J, et al. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. Anticancer Res 1999; 19:3549-3552
-
(1999)
Anticancer Res
, vol.19
, pp. 3549-3552
-
-
Nisman, B.1
Amir, G.2
Lafair, J.3
-
243
-
-
0033024370
-
Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas
-
Fujisawa T, Iizasa T, Saitoh Y, et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 1999; 17:2086-2091
-
(1999)
J Clin Oncol
, vol.17
, pp. 2086-2091
-
-
Fujisawa, T.1
Iizasa, T.2
Saitoh, Y.3
-
244
-
-
0033428435
-
Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer
-
Foa P, Fornier M, Miceli R, et al. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Anticancer Res 1999; 19:3613-3618
-
(1999)
Anticancer Res
, vol.19
, pp. 3613-3618
-
-
Foa, P.1
Fornier, M.2
Miceli, R.3
-
245
-
-
0033776521
-
'Invading edge vs. inner' (edvin) patterns of vascularization: An interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer
-
Giatromanolaki A, Koukourakis MI, Sivridis E, et al. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol 2000; 192:140-149
-
(2000)
J Pathol
, vol.192
, pp. 140-149
-
-
Giatromanolaki, A.1
Koukourakis, M.I.2
Sivridis, E.3
-
246
-
-
0033869662
-
Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer
-
Hirashima T, Komiya T, Nitta T, et al. Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer. Anticancer Res 2000; 20:2181-2187
-
(2000)
Anticancer Res
, vol.20
, pp. 2181-2187
-
-
Hirashima, T.1
Komiya, T.2
Nitta, T.3
-
247
-
-
0342433777
-
Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer
-
Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 2000; 20:1527-1533
-
(2000)
Anticancer Res
, vol.20
, pp. 1527-1533
-
-
Volm, M.1
Koomagi, R.2
-
248
-
-
0034012454
-
Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer
-
Hirasawa Y, Kohno N, Yokoyama A, et al. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer. Am J Respir Crit Care Med 2000; 161:589-594
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 589-594
-
-
Hirasawa, Y.1
Kohno, N.2
Yokoyama, A.3
-
249
-
-
18744431008
-
Biological prognostic factors for early stage completely resected non-small cell lung cancer
-
Cagini L, Monacelli M, Giustozzi G, et al. Biological prognostic factors for early stage completely resected non-small cell lung cancer. J Surg Oncol 2000; 74:53-60
-
(2000)
J Surg Oncol
, vol.74
, pp. 53-60
-
-
Cagini, L.1
Monacelli, M.2
Giustozzi, G.3
-
250
-
-
18744434862
-
Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression
-
Ohsaki Y, Tanno S, Fujita Y, et al. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol Rep 2000; 7:603-607
-
(2000)
Oncol Rep
, vol.7
, pp. 603-607
-
-
Ohsaki, Y.1
Tanno, S.2
Fujita, Y.3
-
251
-
-
0034078113
-
Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma
-
Oyama T, Osaki T, Nose N, et al. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma. Anticancer Res 2000; 20:505-510
-
(2000)
Anticancer Res
, vol.20
, pp. 505-510
-
-
Oyama, T.1
Osaki, T.2
Nose, N.3
-
252
-
-
0034024352
-
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
-
O'Byrne KJ, Koukourakis MI, Giatromanolaki A, et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer 2000; 82:1427-1432
-
(2000)
Br J Cancer
, vol.82
, pp. 1427-1432
-
-
O'Byrne, K.J.1
Koukourakis, M.I.2
Giatromanolaki, A.3
-
253
-
-
0033977670
-
p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
-
Huang CI, Taki T, Higashiyama M, et al. p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung. Br J Cancer 2000; 82:374-380
-
(2000)
Br J Cancer
, vol.82
, pp. 374-380
-
-
Huang, C.I.1
Taki, T.2
Higashiyama, M.3
-
254
-
-
0033915743
-
Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: Putative relation with BCL-2-mediated neovascularization
-
Boldrini L, Calcinai A, Samaritani E, et al. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization. Br J Cancer 2000; 83:480-486
-
(2000)
Br J Cancer
, vol.83
, pp. 480-486
-
-
Boldrini, L.1
Calcinai, A.2
Samaritani, E.3
-
255
-
-
0033931517
-
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer
-
Schneider PM, Praeuer HW, Stoeltzing O, et al. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer. Br J Cancer 2000; 83:473-479
-
(2000)
Br J Cancer
, vol.83
, pp. 473-479
-
-
Schneider, P.M.1
Praeuer, H.W.2
Stoeltzing, O.3
-
256
-
-
0033947298
-
Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases
-
Fukuse T, Hirata T, Naiki H, et al. Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases. Ann Surg 2000; 232:112-118
-
(2000)
Ann Surg
, vol.232
, pp. 112-118
-
-
Fukuse, T.1
Hirata, T.2
Naiki, H.3
-
257
-
-
0034131071
-
Prognostic value of the quantified expression of p185 in non-small cell lung cancer
-
Cantero R, Torres AJ, Maestro ML, et al. Prognostic value of the quantified expression of p185 in non-small cell lung cancer. Thorac Cardiovasc Surg 2000; 119:1119-1125
-
(2000)
Thorac Cardiovasc Surg
, vol.119
, pp. 1119-1125
-
-
Cantero, R.1
Torres, A.J.2
Maestro, M.L.3
-
258
-
-
0033968335
-
Cyclin E expression, a potential prognostic marker for non-small cell lung cancers
-
Mishina T, Dosaka-Akita H, Hommura F, et al. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers. Clin Cancer Res 2000; 6:11-16
-
(2000)
Clin Cancer Res
, vol.6
, pp. 11-16
-
-
Mishina, T.1
Dosaka-Akita, H.2
Hommura, F.3
-
259
-
-
0034100054
-
Predictive survival markers in patients with surgically resected non-small cell lung carcinoma
-
Moldvay J, Scheid P, Wild P, et al. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res 2000; 6:1125-1134
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1125-1134
-
-
Moldvay, J.1
Scheid, P.2
Wild, P.3
-
260
-
-
0034100053
-
p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients
-
Skaug V, Ryberg D, Kure EH, et al. p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients. Clin Cancer Res 2000; 6:1031-1037
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1031-1037
-
-
Skaug, V.1
Ryberg, D.2
Kure, E.H.3
-
261
-
-
0034056981
-
Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer
-
Yano T, Tanikawa S, Fujie T, et al. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer. Eur J Cancer 2000; 36:601-609
-
(2000)
Eur J Cancer
, vol.36
, pp. 601-609
-
-
Yano, T.1
Tanikawa, S.2
Fujie, T.3
-
262
-
-
0033890742
-
Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications
-
Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000; 18:2981-2989
-
(2000)
J Clin Oncol
, vol.18
, pp. 2981-2989
-
-
Andre, F.1
Grunenwald, D.2
Pignon, J.P.3
-
263
-
-
0034489809
-
Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance
-
Kase S, Sugio K, Yamazaki K, et al. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res 2000; 6:4789-4796
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4789-4796
-
-
Kase, S.1
Sugio, K.2
Yamazaki, K.3
-
264
-
-
0034523656
-
Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer
-
Reinmuth N, Brandt B, Kunze WP, et al. Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer. Eur Respir J 2000; 16:991-996
-
(2000)
Eur Respir J
, vol.16
, pp. 991-996
-
-
Reinmuth, N.1
Brandt, B.2
Kunze, W.P.3
-
265
-
-
0034237253
-
Influence of age and predicted forced expiratory volume in 1 s on prognosis following complete resection for non-small cell lung carcinoma
-
Varela G, Novoa N, Jimenez MF. Influence of age and predicted forced expiratory volume in 1 s on prognosis following complete resection for non-small cell lung carcinoma. Eur J Cardiothorac Surg 2000; 18:2-6
-
(2000)
Eur J Cardiothorac Surg
, vol.18
, pp. 2-6
-
-
Varela, G.1
Novoa, N.2
Jimenez, M.F.3
-
266
-
-
0034118679
-
p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland
-
Niklinska W, Burzykowski T, Chyczewski L, et al. p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland. Eur J Cancer Prev 2000; 9:81-87
-
(2000)
Eur J Cancer Prev
, vol.9
, pp. 81-87
-
-
Niklinska, W.1
Burzykowski, T.2
Chyczewski, L.3
-
267
-
-
0033760493
-
Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer
-
Passlick B, Sienel W, Seen-Hibler R, et al. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 2000; 6:3944-3948
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3944-3948
-
-
Passlick, B.1
Sienel, W.2
Seen-Hibler, R.3
-
268
-
-
0034097012
-
Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer
-
Ohta Y, Nozawa H, Tanaka Y, et al. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. Thorac Cardiovasc Surg 2000; 119:804-813
-
(2000)
Thorac Cardiovasc Surg
, vol.119
, pp. 804-813
-
-
Ohta, Y.1
Nozawa, H.2
Tanaka, Y.3
-
269
-
-
0033626566
-
Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers
-
Hommura F, Dosaka-Akita H, Mishina T, et al. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Clin Cancer Res 2000; 6:4073-4081
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4073-4081
-
-
Hommura, F.1
Dosaka-Akita, H.2
Mishina, T.3
-
270
-
-
0033981030
-
Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer
-
Blaes F, Klotz M, Huwer H, et al. Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer. Ann Thorac Surg 2000; 69:254-258
-
(2000)
Ann Thorac Surg
, vol.69
, pp. 254-258
-
-
Blaes, F.1
Klotz, M.2
Huwer, H.3
-
271
-
-
0033793914
-
Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer
-
Jazieh AR, Hussain M, Howington JA, et al. Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg 2000; 70:1168-1171
-
(2000)
Ann Thorac Surg
, vol.70
, pp. 1168-1171
-
-
Jazieh, A.R.1
Hussain, M.2
Howington, J.A.3
-
272
-
-
0034531389
-
Neopterin: A prognostic variable in operations for lung cancer
-
Prommegger R, Widner B, Murr C, et al. Neopterin: a prognostic variable in operations for lung cancer. Ann Thorac Surg 2000; 70:1861-1864
-
(2000)
Ann Thorac Surg
, vol.70
, pp. 1861-1864
-
-
Prommegger, R.1
Widner, B.2
Murr, C.3
-
273
-
-
0034307043
-
Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma
-
Shiba M, Kohno H, Kakizawa K, et al. Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma. Cancer 2000; 89:1457-1465
-
(2000)
Cancer
, vol.89
, pp. 1457-1465
-
-
Shiba, M.1
Kohno, H.2
Kakizawa, K.3
-
274
-
-
0033946522
-
MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer
-
Ko JL, Cheng YW, Chang SL, et al. MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer. Int J Cancer 2000; 89:265-270
-
(2000)
Int J Cancer
, vol.89
, pp. 265-270
-
-
Ko, J.L.1
Cheng, Y.W.2
Chang, S.L.3
-
275
-
-
0034693631
-
Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer
-
Yuan A, Yu CJ, Chen WJ, et al. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer 2000; 89:475-483
-
(2000)
Int J Cancer
, vol.89
, pp. 475-483
-
-
Yuan, A.1
Yu, C.J.2
Chen, W.J.3
-
276
-
-
0034692447
-
Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer
-
Tang X, Khuri FR, Lee JJ, et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 2000; 92:1511-1516
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 1511-1516
-
-
Tang, X.1
Khuri, F.R.2
Lee, J.J.3
-
277
-
-
0033694997
-
Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer
-
Yuan A, Yang PC, Yu CJ, et al. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med 2000; 162:1957-1963
-
(2000)
Am J Respir Crit Care Med
, vol.162
, pp. 1957-1963
-
-
Yuan, A.1
Yang, P.C.2
Yu, C.J.3
-
278
-
-
0035866413
-
Prognostic significance of polysialic acid expression in resected non-small cell lung cancer
-
Tanaka F, Otake Y, Nakagawa T, et al. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer. Cancer Res 2001; 61:1666-1670
-
(2001)
Cancer Res
, vol.61
, pp. 1666-1670
-
-
Tanaka, F.1
Otake, Y.2
Nakagawa, T.3
-
279
-
-
0035863322
-
Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer
-
Muller-Tidow C, Metzger R, Kugler K, et al. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res 2001; 61:647-653
-
(2001)
Cancer Res
, vol.61
, pp. 647-653
-
-
Muller-Tidow, C.1
Metzger, R.2
Kugler, K.3
-
280
-
-
0034974069
-
Prognostic markers in resectable non-small cell lung cancer: A multivariate analysis
-
Pelletier MP, Edwardes MD, Michel RP, et al. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 2001; 44:180-188
-
(2001)
Can J Surg
, vol.44
, pp. 180-188
-
-
Pelletier, M.P.1
Edwardes, M.D.2
Michel, R.P.3
-
281
-
-
0034949214
-
A biological staging model for operable non-small cell lung cancer
-
Cox G, Jones JL, Andi A, et al. A biological staging model for operable non-small cell lung cancer. Thorax 2001; 56:561-566
-
(2001)
Thorax
, vol.56
, pp. 561-566
-
-
Cox, G.1
Jones, J.L.2
Andi, A.3
-
282
-
-
0035863288
-
Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer
-
Yuan A, Yu CJ, Kuo SH, et al. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol 2001; 19:432-441
-
(2001)
J Clin Oncol
, vol.19
, pp. 432-441
-
-
Yuan, A.1
Yu, C.J.2
Kuo, S.H.3
-
283
-
-
0035863302
-
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy
-
Schiller JH, Adak S, Feins RH, et al. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy. J Clin Oncol 2001; 19:448-457
-
(2001)
J Clin Oncol
, vol.19
, pp. 448-457
-
-
Schiller, J.H.1
Adak, S.2
Feins, R.H.3
-
284
-
-
0035040809
-
Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer
-
Vassilakopoulos T, Troupis T, Sotiropoulou C, et al. Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer. Lung Cancer 2001; 32:137-144
-
(2001)
Lung Cancer
, vol.32
, pp. 137-144
-
-
Vassilakopoulos, T.1
Troupis, T.2
Sotiropoulou, C.3
-
285
-
-
0035834870
-
Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas
-
Puglisi F, Aprile G, Bruckbauer M, et al. Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas. Cancer Lett 2001; 162:97-103
-
(2001)
Cancer Lett
, vol.162
, pp. 97-103
-
-
Puglisi, F.1
Aprile, G.2
Bruckbauer, M.3
-
286
-
-
0035155064
-
Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis
-
Han H, Silverman JF, Santucci TS, et al. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann Surg Oncol 2001; 8:72-79
-
(2001)
Ann Surg Oncol
, vol.8
, pp. 72-79
-
-
Han, H.1
Silverman, J.F.2
Santucci, T.S.3
-
287
-
-
0035106231
-
Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer
-
Kara M, Ohta Y, Tanaka Y, et al. Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer. Ann Thorac Surg 2001; 71:944-948
-
(2001)
Ann Thorac Surg
, vol.71
, pp. 944-948
-
-
Kara, M.1
Ohta, Y.2
Tanaka, Y.3
-
288
-
-
0035059312
-
Visceral pleura invasion by non-small cell lung cancer: An underrated bad prognostic factor
-
Manac'h D, Riquet M, Medioni J, et al. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg 2001; 71:1088-1093
-
(2001)
Ann Thorac Surg
, vol.71
, pp. 1088-1093
-
-
Manac'h, D.1
Riquet, M.2
Medioni, J.3
-
289
-
-
0035878613
-
Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma
-
Izumi M, Nakanishi Y, Yoshino I, et al. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 2001; 92:446-451
-
(2001)
Cancer
, vol.92
, pp. 446-451
-
-
Izumi, M.1
Nakanishi, Y.2
Yoshino, I.3
-
290
-
-
0035871403
-
Patterns of angiogenesis in nonsmall-cell lung carcinoma
-
Offersen BV, Pfeiffer P, Hamilton-Dutoit S, et al. Patterns of angiogenesis in nonsmall-cell lung carcinoma. Cancer 2001; 91:1500-1509
-
(2001)
Cancer
, vol.91
, pp. 1500-1509
-
-
Offersen, B.V.1
Pfeiffer, P.2
Hamilton-Dutoit, S.3
|